(Q43465890)

23 November 2017

title

Can categorization of patient background problems be used to determine early termination in a clinical trial? (English)

1 reference

23 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3356152

30 December 2022

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

30 December 2022

author name string

J. A. Cramer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3356152

30 December 2022

J. F. Collins

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3356152

30 December 2022

R. H. Mattson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3356152

30 December 2022

language of work or name

English

0 references

publication date

1 March 1988

1 reference

full work available at URL

23 November 2017

https://api.elsevier.com/content/article/PII:0197245688900086?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

https://api.elsevier.com/content/article/PII:0197245688900086?httpAccept=text/plain

30 December 2022

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

Contemporary Clinical Trials

30 December 2022

published in

1 reference

23 November 2017

volume

9

1 reference

23 November 2017

issue

1

1 reference

23 November 2017

page(s)

47-63

1 reference

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

23 November 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

A design for the prospective evaluation of the efficacy and toxicity of antiepileptic drugs in adults

30 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

A method of quantification for the evaluation of antiepileptic drug therapy

30 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

Can dropout and other noncompliance be minimized in a clinical trial? Report from the Veterans Administrative National Heart, Lung and Blood Institute cooperative study on antihypertensive therapy: mild hypertension

30 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

Shaping a clinic population: the dropout problem reconsidered.

30 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

DROPOUT IN AN OUTPATIENT, DOUBLE-BLIND DRUG STUDY

30 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

Predicting which patients will be discharged against medical advice: a pilot study

30 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

Appointment systems: why does a patient not return?

30 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

Dropping out of treatment: A critical review

30 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

Propranolol in hypertensive dialysis patients: Efficacy and compliance

30 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

Diagnosis and management of patient noncompliance.

30 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0197-2456(88)90008-6

30 December 2022

Identifiers

1 reference

23 November 2017

1 reference